English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 11 October 2022, 07:20 HKT/SGT
Share:
        

Source: Solve.Care / ClinicalSquared
ClinicalSquared Partners with Solve.Care to Create Web3 Health Networks on the Blockchain
ClinicalSquared to act as authoring agents, enabling quicker turn-around time for the deployment of digital health networks on the Solve.Care Platform.

Washington, D.C., Oct 11, 2022 - (ACN Newswire) - Solve.Care (https://solve.care/), a healthcare platform company that leverages blockchain to deliver better care and ClinicalSquared (www.clinicalsquared.com), a multi-disciplinary technology consulting company specializing in custom software development, today announced that they have joined forces to create Web3 health networks on the Solve.Care Platform. The announcement was made at the Blockchain & Infrastructure Conference held at the National Press Club in Washington DC, and organized by the Government Blockchain Association.


The decentralized Care.Platform from Solve.Care allows for the quick creation and deployment of interoperable health networks. Governments, businesses and even individuals can author their own networks using the Care.Labs low-code development portal.

Digital health networks on the Care.Platform are known as Care.Networks. Data in Care.Networks are stored on decentralized nodes, where all interactions and transactions are automatically tokenized. They can be authored without the need for any Web3 or blockchain knowledge. Care.Network owners can also opt to outsource the authoring of their Care.Networks to any third party or utilize ClinicalSquared, having been appointed as the official authoring agent of Care.Platform.

Pradeep Goel, CEO of Solve.Care said, "Having ClinicalSquared on board, enables for our clients to have their Care.Networks rolled out to the market at an even quicker timeframe. While our clients are in the best position to know when they want from their Care.Networks, they may not always have the capacity to author them. It is about giving our clients options that best serve their interests."

Marquis Allen, CEO of ClinicalSquared said, "We are excited to partner with the Solve.Care team, leveraging our skills, technical resources, and formidable experience in the healthcare IT sector to accelerate the development of blockchain-featured healthcare solutions. We welcome the opportunity to serve."

Both ClinicalSquared and Solve.Care are members of the Government Blockchain Association (GBA) (https://gbaglobal.org/). The GBA is an association that connects people and organizations with blockchain technology-based solutions to problems typically faced by government entities.

Source: Platodata Intelligence https://platodata.io

Topic: Press release summary
Source: Solve.Care / ClinicalSquared

Sectors: Healthcare & Pharm, Blockchain Technology
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
The New Soluble Solid by MASSCON  
Aug 7, 2024 14:00 HKT/SGT
Glow Up With The Shilla Duty Free This Summer  
Aug 7, 2024 09:00 HKT/SGT
TANAKA Precious Metals to Reorganize Group Organizational Structure from January 2025  
Wednesday, August 7, 2024 2:00:00 AM
Jeff Cooperstein Named Kadena Business Development Lead, Digital Assets  
Aug 6, 2024 23:00 HKT/SGT
GMG's Graphene Aluminium-Ion Battery: Progress Update and Next Steps Toward Commercialisation  
Aug 6, 2024 20:09 HKT/SGT
Food Expo Kicks Off Next Week with Four Thematic Days to Explore Infinite Lifestyle Possibilities  
Aug 6, 2024 20:06 HKT/SGT
DENSO Signs Manufacturing License Agreement for SOEC Cell Stacks with Ceres Power Holdings of the UK  
Tuesday, August 6, 2024 7:21:00 PM
U.S. Polo Assn. Moves Up Two Spots in License Global's Top 25 'Top Global Licensors'  
Aug 6, 2024 19:00 HKT/SGT
Mitsubishi Heavy Industries Achieves Strong YoY Increases in Order Intake, Revenue, and Profit in Q1 FY2024  
Tuesday, August 6, 2024 2:25:00 PM
Eisai: Update Regarding the Regulatory Status of LEQEMBI Subcutaneous Formulation  
Tuesday, August 6, 2024 12:15:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575